bioRxivImmunologyPreprint
Glycosylation-dependent modulation of the lL-2 signaling axis determines Th17 differentiation and IL-10 production
Leona GabryšováiD, Elizabeth H. Mann, Lydia Bradley, James I. MacRae, Charlotte Whicher, Catherine M. Hawrylowicz, Dimitrios Anastasiou, Anne O’Garra
Abstract
Metabolism plays an essential role in shaping T helper (Th) cell responses including the production of pro-inflammatory cytokines, however the effects on IL-10 have not been investigated. We show that the glucose analogue 2-deoxyglucose (2DG) specifically inhibits Th1 and Th2 cell differentiation and accompanying IL-10 production. In contrast, 2DG promotes IL-17A production by Th17 cells, even in the presence of IL-2 known to limit Th17 differentiation, whilst totally abrogating the production of IL-10. Notably, rather than inhibiting glycolysis, 2DG acts through the inhibition of glycosylation, which is critical for IL-2R surface expression and downstream signaling in both mouse and man. Strikingly, IL-2 is essential for IL-10 production by Th17 cells, in contrast to its inhibitory effect on the production of IL-17A. Our study reveals a previously unappreciated, anti-inflammatory role for IL-2 in Th17 cell production of IL-10 and thus identifies a novel mechanism to limit Th17 pathogenicity.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Modulation of glucose metabolism by 2-Deoxy-D-Glucose (2DG) promotes IL-17 producing human T cell subsets
X. Chen, L. Kozhaya, … D. Unutmaz·bioRxiv·Mar 13, 2022
- The glycolytic reaction PGAM unexpectedly restrains Th17 pathogenicity and Th17-dependent autoimmunity
Chao Wang, Allon Wagner, … Vijay Kumar Kuchroo·Cell ReportsPeer-reviewed·Jun 1, 2025
- O-GlcNAcylation and low glycolysis underpin Th2 polarization by dendritic cells
Leonard R. Pelgrom, Marjolein Quik, … Bart Everts·bioRxiv·Feb 5, 2026
- Glycolytic flux sustains human Th1 identity and effector function via STAT1 glycosylation
Ariful Haque Abir, Julia Benz, … Dirk Mielenz·Life Science AlliancePeer-reviewed·Oct 22, 2025
- Niche-selective inhibition of pathogenic Th17 cells by targeting metabolic redundancy
L. Wu, K. E. R. Hollinshead, … D. R. Littman·bioRxiv·Jun 10, 2020
- Akt2 deficiency impairs Th17 differentiation, augments Th2 differentiation, and alters the peripheral response to immunization
Lauren Baker Banks, Tammarah Sklarz, … Martha S. Jordan·bioRxiv·Jun 7, 2024